TerminatedNCT03693105
The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition
Device studyAges 18–75United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- Iowa City and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 30, 2024
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 2
- Sponsor
- Magnus Medical
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT03693105
- Official title
Show the full official title
A Multi-Site, Randomized, Double-Blind Trial Assessing The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Iowa City · Manhattan · Charleston
1 more locations
- Austin
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Magnus Medical.
Who can participate?
Listed age limits: 18 years to 75 years.
Is this study still recruiting?
The registry lists this study as terminated.
